Post-transcriptional gene regulation makes things clearer in renal fibrosis

Journal of the American Society of Nephrology

Volumn 24, Issue 7, 2013, Pages 1026-1028

  Tomasoni, Susanna ^a   Benigni, Ariela ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE COURSE; EDITORIAL; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY POLYCYSTIC DISEASE; PRIORITY JOURNAL; REGULATORY MECHANISM; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 84879920799     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2013040411     Document Type: Editorial

References (23)

1. Bhatt K, Mi QS, Dong Z: microRNAs in kidneys: Biogenesis, regulation, and pathophysiological roles. Am J Physiol Renal Physiol 300: F602-F610, 2011
2. Nagalakshmi VK, Ren Q, Pugh MM, Valerius MT, McMahon AP, Yu J: Dicer regulates the development of nephrogenic and ureteric compartments in the mammalian kidney. Kidney Int 79: 317-330, 2011
3. Sun Y, Koo S,White N, Peralta E, EsauC,DeanNM, Perera RJ:Development of a micro-Array to detect human and mouse microRNAs and characterization of expression in human organs. Nucleic Acids Res 32: e188, 2004
4. Chandrasekaran K, Karolina DS, Sepramaniam S, Armugam A, Wintour EM, Bertram JF, Jeyaseelan K: Role of microRNAs in kidney homeostasis and disease. Kidney Int 81: 617-627, 2012
5. Gebeshuber CA, Kornauth C, Dong L, Sierig R, Seibler J, Reiss M, Tauber S, BilbanM,Wang S, Kain R, BöhmigGA,MoellerMJ,GröneHJ, Englert C,Martinez J, KerjaschkiD: Focal segmental glomerulosclerosis is induced bymicroRNA-193a and its downregulation ofWT1. NatMed 19: 481-487, 2013
6. Chung AC, Dong Y, Yang W, Zhong X, Li R, Lan HY: Smad7 suppresses renal fibrosis via altering expression of TGF-b/Smad3-regulated microRNAs. Mol Ther 21: 388-398, 2013
7. Qin W, Chung AC, Huang XR, Meng XM, Hui DS, Yu CM, Sung JJ, Lan HY: TGF-b/Smad3 signaling promotes renal fibrosis by inhibiting miR-29. J AmSoc Nephrol 22: 1462-1474, 2011
8. Lan HY, Chung AC: TGF-b/Smad signaling in kidney disease. Semin Nephrol 32: 236-243, 2012
9. Liang D, Shen N: MicroRNA involvement in lupus: The beginning of a new tale. Curr Opin Rheumatol 24: 489-498, 2012
10. LuMC, LaiNS, Chen HC, YuHC,Huang KY, Tung CH,HuangHB, YuCL: Decreased microRNA(miR)-145 and increased miR-224 expression in T cells frompatients with systemic lupus erythematosus involved in lupus immunopathogenesis. Clin Exp Immunol 171: 91-99, 2013
11. Carlsen AL, Schetter AJ, Nielsen CT, Lood C, Knudsen S, Voss A, Harris CC, Hellmark T, Segelmark M, Jacobsen S, Bengtsson AA, Heegaard NH: Circulating microRNA expression profiles associated with systemic lupus erythematosus. Arthritis Rheum 65: 1324-1334, 2013
12. Dai Y, SuiW, Lan H, YanQ, Huang H, Huang Y: Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients. Rheumatol Int 29: 749-754, 2009
13. Lu J, Kwan BC, Lai FM, Tam LS, Li EK, Chow KM, Wang G, Li PK, Szeto CC: Glomerular and tubulointerstitial miR-638, miR-198 and miR-146a expression in lupus nephritis. Nephrology (Carlton) 17: 346-351, 2012
14. Zhou H, Hasni SA, Perez P, Tandon M, Jang S, Zheng C, Kopp JB, Austin H 3rd, Balow JE, Alevizos I, Illei GG: miR-150 promotes renal fibrosis in lupus nephritis by downregulating SOCS1. J AmSocNephrol 24: 1073-1087, 2013
15. MacconiD, Tomasoni S, Romagnani P, Trionfini P, Sangalli F, Mazzinghi B, Rizzo P, Lazzeri E, Abbate M, Remuzzi G, Benigni A: MicroRNA-324-3p promotes renal fibrosis and is a target of ACE inhibition. J Am Soc Nephrol 23: 1496-1505, 2012
16. Ronconi E, Sagrinati C, AngelottiML, Lazzeri E,Mazzinghi B, Ballerini L, Parente E, Becherucci F, Gacci M, Carini M, Maggi E, Serio M, Vannelli GB, Lasagni L, Romagnani S, Romagnani P: Regeneration of glomerular podocytes by human renal progenitors. J Am Soc Nephrol 20: 322-332, 2009
17. Benigni A, Morigi M, Rizzo P,Gagliardini E, Rota C, AbbateM,Ghezzi S, Remuzzi A, Remuzzi G: Inhibiting angiotensin-converting enzyme promotes renal repair by limiting progenitor cell proliferation and restoring the glomerular architecture. Am J Pathol 179: 628-638, 2011
18. FujimotoM, Tsutsui H, XinshouO, TokumotoM,Watanabe D, Shima Y, Yoshimoto T, Hirakata H, Kawase I, Nakanishi K, Kishimoto T, Naka T: Inadequate induction of suppressor of cytokine signaling-1 causes systemic autoimmune diseases. Int Immunol 16: 303-314, 2004
19. Ortiz-Muñoz G, Lopez-Parra V, Lopez-Franco O, Fernandez-Vizarra P, Mallavia B, Flores C, Sanz A, Blanco J, Mezzano S, Ortiz A, Egido J, Gomez-Guerrero C: Suppressors of cytokine signaling abrogate diabetic nephropathy. J Am Soc Nephrol 21: 763-772, 2010
20. Chan HC, Ke LY, Chang LL, LiuCC,Hung YH, Lin CH, Li RN, TsaiWC, Liu HW, Yen JH: Suppressor of cytokine signaling 1 gene expression and polymorphisms in systemic lupus erythematosus. Lupus 19: 696-702, 2010
21. Krishnan MR, Wang C, Marion TN: Anti-DNA autoantibodies initiate experimental lupus nephritis by binding directly to the glomerular basement membrane in mice. Kidney Int 82: 184-192, 2012
22. Metcalf JL, Bradshaw PS, Komosa M, Greer SN, StephenMeynM, Ohh M: K63-Ubiquitylation of VHL by SOCS1 mediates DNA double-strand break repair [published online ahead of print March 4, 2013]. Oncogene doi:10.1038/onc.2013. 22
23. Thomas MC: Emerging drugs for managing kidney disease in patients with diabetes. Expert Opin Emerg Drugs 18: 55-70, 2013